Sweis RF, et al. Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer. ASCO-GU 2019, abstract 423.
Zorginstituut adviseert over toelating pembrolizumab (Keytruda) bij TNBC
mei 2024 | Borstkanker